Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
TBM100
DRUG
2 trials
Sponsors
Novartis Pharmaceuticals
Conditions
Long-term Safety of TIP
Pseudomonas Aeruginosa in Cystic Fibrosis
Pulmonary Infections
Phase 4
Long Term Safety of Tobramycin Inhalation Powder in Patients With Cystic Fibrosis
Completed
NCT01519661
Novartis Pharmaceuticals
Pseudomonas Aeruginosa in Cystic Fibrosis, Pulmonary Infections
Start: 2012-01-31
End: 2014-01-31
Updated: 2015-02-10
Ext. Long-term Safety Study in CF Patients: Single Arm TIP
Completed
NCT01775137
Novartis Pharmaceuticals
Long-term Safety of TIP
Start: 2013-02-28
End: 2014-11-30
Updated: 2015-11-06
Related Papers
Long-term safety of tobramycin inhalation powder in patients with cystic fibrosis: phase IV (ETOILES) study.
2016-09-09
12 citations